Association of heart rate with heart failure outcomes and the effects of empagliflozin in patients with preserved ejection fraction - EMPEROR-Preserved trial

被引：0
|
作者：
Boehm, M. [1 ]
Anker, S. D. [2 ]
Mahfoud, F. [1 ]
Filippatos, G. [3 ]
Ferreira, J. P. [4 ]
Pocock, S. J. [5 ]
Brueckmann, M. [6 ]
Linetzky, B. [7 ]
Schueler, E. [8 ]
Wanner, C. [9 ]
Zannad, F. [4 ]
Packer, M. [10 ]
Butler, J. [11 ]
机构：
[1] Univ Hosp Saarland, Clin Internal Med Cardiol Angiol & Intens Care Me, Homburg, Germany
[2] Charite Univ Med Berlin, Dept Cardiol CVK, Berlin, Germany
[3] Natl & Kapodistrian Univ Athens, Athens Univ Hosp, Sch Med, Athens, Greece
[4] Univ Lorraine, Nancy, France
[5] London Sch Hyg & Trop Med, London, England
[6] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[7] Eli Lilly Interamer Inc, Buenos Aires, DF, Argentina
[8] mainanalyt GmbH, Sulzbach, Germany
[9] Wuerzburg Univ Clin, Wurzburg, Germany
[10] Baylor Univ Med Ctr, Dallas, TX USA
[11] Baylor Scott & White Hlth, Dallas, TX USA
来源：
EUROPEAN HEART JOURNAL | 2022年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：983 / 983
页数：1
相关论文
共 50 条
  • [11] EMPAGLIFLOZIN IN HEART FAILURE WITH A PRESERVED EJECTION FRACTION ≥50%: RESULTS FROM THE EMPEROR-PRESERVED CLINICAL TRIAL
    Yousef, Zaheer
    HEART, 2022, 108 : A79 - A80
  • [12] Uric Acid and Treatment With Empagliflozin in Heart Failure with Preserved Ejection Fraction (HFpEF): the EMPEROR-Preserved Trial
    Green, Jennifer
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2023, 142 : S25 - S25
  • [13] Empagliflozin in Heart Failure With a Preserved Ejection Fraction ≥50% - Results From the EMPEROR-Preserved Clinical Trial
    Anker, Stefan D.
    CIRCULATION, 2021, 144 (25) : E571 - E572
  • [14] The Emperor-Preserved trial: what will change for patients with heart failure with preserved ejection fraction?
    Deaton, Christi
    EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2022, 21 (04) : 293 - 294
  • [15] Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial
    Anker, Stefan D.
    Butler, Javed
    Filippatos, Gerasimos
    Shahzeb Khan, Muhammad
    Pedro Ferreira, Joao
    Bocchi, Edimar
    Bohm, Michael
    Pieter Brunner-La Rocca, Hans
    Choi, Dong-Ju
    Chopra, Vijay
    Chuquiure, Eduardo
    Giannetti, Nadia
    Esteban Gomez-Mesa, Juan
    Janssens, Stefan
    Januzzi, James L.
    Gonzalez-Juanatey, Jose R.
    Merkely, Bela
    Nicholls, Stephen J.
    Perrone, Sergio, V
    Pina, Ileana L.
    Ponikowski, Piotr
    Senni, Michele
    Seronde, Marie-France
    Sim, David
    Spinar, Jindrich
    Squire, Iain
    Taddei, Stefano
    Tsutsui, Hiroyuki
    Verma, Subodh
    Vinereanu, Dragos
    Zhang, Jian
    Jamal, Waheed
    Schnaidt, Sven
    Schnee, Janet M.
    Brueckmann, Martina
    Pocock, Stuart J.
    Zannad, Faiez
    Packer, Milton
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (12) : 2383 - 2392
  • [16] Efficacy of empagliflozin in heart failure with preserved ejection fraction according to frailty status in EMPEROR-Preserved
    Coats, Andrew J. S.
    Butler, Javed
    Tsutsui, Hiroyuki
    Doehner, Wolfram
    Filippatos, Gerasimos
    Ferreira, Joao Pedro
    Boehm, Michael
    Chopra, Vijay K.
    Verma, Subodh
    Nordaby, Matias
    Iwata, Tomoko
    Nitta, Daisuke
    Ponikowski, Piotr
    Zannad, Faiez
    Packer, Milton
    Anker, Stefan D.
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2024, 15 (01) : 412 - 424
  • [17] Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection: The EMPEROR-Preserved Trial
    Butler, Javed
    CIRCULATION, 2021, 144 (25) : E585 - E586
  • [18] Effects of empagliflozin in patients with heart failure and preserved ejection fraction according to baseline diuretic use: results from the EMPEROR-Preserved trial
    Butler, J.
    EUROPEAN HEART JOURNAL, 2022, 43 : 982 - 982
  • [19] Outcomes of empagliflozin in patients with heart failure with a preserved ejection fraction and atrial fibrillation or atrial flutter: insights from EMPEROR-Preserved
    Filippatos, Gerasimos
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 134 - 135
  • [20] Safety and Efficacy of Empagliflozin and Diuretic Use in Patients with Heart Failure and Preserved Ejection Fraction A Post Hoc Analysis of the EMPEROR-Preserved Trial
    Butler, Javed
    Usman, Muhammad Shariq
    Filippatos, Gerasimos
    Ferreira, Joao Pedro
    Boehm, Michael
    Brueckmann, Martina
    Januzzi, James L.
    Kaul, Sanjay
    Pina, Ileana L.
    Ponikowski, Piotr
    Senni, Michele
    Sumin, Mikhail
    Verma, Subodh
    Zaremba-Pechmann, Liliana
    Pocock, Stuart J.
    Packer, Milton
    Anker, Stefan
    JAMA CARDIOLOGY, 2023, 8 (07) : 640 - 649
12345